BRAIN & BEHAVIOR FOUNDATION ANNOUNCES WEBINARS ON SCHIZOPHRENIA, ADHD & BRAIN PLASTICITY
—Nation’s top researchers to share research findings and answer questions posed by online participants—
NEW YORK CITY (February 5, 2014)—The Brain & Behavior Research Foundation today announced the winter schedule for its popular monthly webinars during which leading mental health researchers discuss and answer questions about the latest in new technologies, early intervention strategies and next-generation therapies for mental illness. Researchers from the University of Maryland, the NYU Child Study Center and The Rockefeller University will discuss schizophrenia, ADHD and brain plasticity, respectively.
“These popular webinars offer the general public access to some of the world’s top scientists who discuss their cutting-edge research that could lead to breakthroughs alleviating suffering caused by mental illness,” said Dr. Jeffrey Borenstein, M.D., the Chief Executive Officer of the Brain & Behavior Research Foundation and host of the award-winning television series “Healthy Minds.”
Each of the hour-long monthly webinars includes time for researchers to answer questions posed by the online participants. Dr. Borenstein will moderate all discussions. Each webinar will be live tweeted with the hashtag #brainchat. After the live event, recordings of the webinars will be available on the Foundation’s website at: bbrfoundation.org/webinar.
The upcoming webinars are:
February 11, 2-3 p.m. EST
NEW APPROACHES FOR THERAPEUTIC DISCOVERY IN SCHIZOPHRENIA
Dr. William T. Carpenter, M.D., the Professor of Psychiatry and Pharmacology at the University of Maryland School of Medicine in Baltimore, will discuss his research integrating animal, human and clinical models to develop novel therapeutics. Throughout his prolific career, Dr. Carpenter’s research into schizophrenia has helped uncover its symptoms, courses, and causes and shaped the prevention and treatment of this severe mental illness. His approach to the care and study of patients has encompassed a medical model integrating biological, psychological and social data pertinent to diagnosis, treatment and etiology. Dr. Carpenter is also a member of the Brain & Behavior Research Foundation’s Scientific Council and three-time NARSAD Grantee.
March 11, 2-3 p.m. EST
ADHD: NEURODEVELOPMENTAL DISORDER THROUGH THE AGES
A renowned researcher, Rachel G. Klein, Ph.D., has devoted her career to studying treatments for attention-deficit hyperactivity disorder (ADHD), learning disorders, anxiety disorders, and depression. Her longitudinal studies have demonstrated the need for early identification of childhood psychiatric disorders, large-scale prevention programs, and individualized treatment plans. As director of the NYU Child Study Center’s Anita Saltz Institute for Anxiety and Mood Disorders, Dr. Klein has mentored many of the nation’s leading researchers in child and adolescent psychiatry. Recently, she published findings from research funded by a NARSAD Grant that showed men who were diagnosed with ADHD as children still struggled in adult life. An honorary fellow of the American Psychiatric Association, she has authored seven books and over 200 scholarly articles.
April 8, 2-3 p.m. EST
BRAIN PLASTICITY: WHAT IS IT AND WHY IS IT IMPORTANT?
Bruce S. McEwen, Ph.D., a BBRF Scientific Council Member and the Alfred E. Mirsky Professor at The Rockefeller University, will discuss how experiences, such as learning a new task or memorizing new information, reorganize neural pathways in the brain and create long lasting functional changes in the brain―an adaptive capacity called brain plasticity. Dr. McEwen’s research has contributed significantly to advancing the understanding of brain plasticity as well as to elucidating the impact of stress and sex hormones on the brain’s chemistry and structure. Dr. McEwen’s emphasis is on the mechanisms underlying adaptive structural plasticity. In studying both stress and sex hormones as regulators of structural plasticity in the adult brain, Dr. McEwen and his team examine sex differences and how they develop, along with the influence of early life experiences, in affecting learning, memory and predisposition towards disease.
About Jeffrey Borenstein
Jeffrey Borenstein, M.D., the President & Chief Executive Officer of the Brain & Behavior Research Foundation, has more than two decades of experience in health and non-profit leadership. He is former CEO/Medical Director of Holliswood Hospital, where he served from 1996 to 2012. He is a board-certified psychiatrist and the host of the award-winning series, “Healthy Minds,” which is broadcast on public television stations across the United States. He is Editor-in-Chief of Psychiatric News, the newspaper of the American Psychiatric Association.
About the Brain & Behavior Research Foundation
The Brain & Behavior Research Foundation (formerly known as NARSAD or the National Alliance for Research on Schizophrenia and Depression) raises funds to invest in cutting-edge research projects to understand, treat, and ultimately prevent and cure mental illness. Since 1987, the Foundation has awarded over $300 million in its NARSAD Research Grants to more than 3,700 scientists around the world. Research projects are selected by the Foundation’s Scientific Council comprised of 146 leading experts across disciplines in brain and behavior research. Funded through private contributions, the Foundation invests 100% of donor contributions for research directly into its NARSAD Grants.